Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Lin

Showing results (121-130 of 328) with videos related to

Pageof 33
Sort By:
Current Oncology Reports|February 22, 2022
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and TreatmentEfstratios Koutroumpakis, Anita Deswal, Syed Wamique Yusuf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2018
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using <sup>18</sup>F-FDG PET/CTLucas Goense, Jelle P Ruurda, Brett W Carter, et al.
Cell Research|January 18, 2020
The role of ferroptosis in ionizing radiation-induced cell death and tumor suppressionGuang Lei, Yilei Zhang, Pranavi Koppula, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2025
Defining the Optimal Radiation-induced Lymphopenia Metric to Discern Its Survival Impact in Esophageal CancerPim J J Damen, Max Peters, Brian Hobbs, et al.
Advances in Radiation Oncology|October 21, 2020
Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal AdenocarcinomaWei Deng, Krishan R Jethwa, Karthik Gonuguntla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2016
Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with ChemoradiationYifan Wang, Hui Liu, Lixia Diao, et al.
American Journal of Hematology|January 11, 2022
Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysisMalgorzata K Nowakowska, Taebeom Kim, Mikayla T Thompson, et al.
Cancers|March 10, 2022
The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal CancerXin Wang, Nicolas L Palaskas, Brian P Hobbs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2019
Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLCAmy C Moreno, Bryan Fellman, Brian P Hobbs, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2013
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancerDaniel R Gomez, Michael Gillin, Zhongxing Liao, et al.
Pageof 33

Showing results (121-130 of 328) with videos related to

Sort By:
Pageof 33
Current Oncology Reports|February 22, 2022
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and TreatmentEfstratios Koutroumpakis, Anita Deswal, Syed Wamique Yusuf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2018
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using <sup>18</sup>F-FDG PET/CTLucas Goense, Jelle P Ruurda, Brett W Carter, et al.
Cell Research|January 18, 2020
The role of ferroptosis in ionizing radiation-induced cell death and tumor suppressionGuang Lei, Yilei Zhang, Pranavi Koppula, et al.
International Journal of Radiation Oncology, Biology, Physics|January 4, 2025
Defining the Optimal Radiation-induced Lymphopenia Metric to Discern Its Survival Impact in Esophageal CancerPim J J Damen, Max Peters, Brian Hobbs, et al.
Advances in Radiation Oncology|October 21, 2020
Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal AdenocarcinomaWei Deng, Krishan R Jethwa, Karthik Gonuguntla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2016
Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with ChemoradiationYifan Wang, Hui Liu, Lixia Diao, et al.
American Journal of Hematology|January 11, 2022
Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysisMalgorzata K Nowakowska, Taebeom Kim, Mikayla T Thompson, et al.
Cancers|March 10, 2022
The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal CancerXin Wang, Nicolas L Palaskas, Brian P Hobbs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2019
Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLCAmy C Moreno, Bryan Fellman, Brian P Hobbs, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2013
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancerDaniel R Gomez, Michael Gillin, Zhongxing Liao, et al.
Pageof 33